Free Trial

Actuate Therapeutics (ACTU) News Today

Actuate Therapeutics logo
$8.94 -0.06 (-0.67%)
(As of 11/22/2024 ET)
Actuate Therapeutics stock logo
Actuate Therapeutics (NASDAQ:ACTU) Trading Down 2.8% - Should You Sell?
Actuate Therapeutics (NASDAQ:ACTU) Shares Down 2.8% - Here's What Happened
Actuate Therapeutics Inc ACTU
Actuate Therapeutics stock logo
Actuate Therapeutics' (NASDAQ:ACTU) Quiet Period Set To Expire on September 23rd
Actuate Therapeutics' (NASDAQ:ACTU - Get Free Report) quiet period will expire on Monday, September 23rd. Actuate Therapeutics had issued 2,800,000 shares in its IPO on August 13th. The total size of the offering was $22,400,000 based on an initial share price of $8.00. During the company's quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
Actuate Therapeutics Inc (ACTU)
Actuate Therapeutics, Inc. Common stock (ACTU)
Get Actuate Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACTU and its competitors with MarketBeat's FREE daily newsletter.

Trump Wins… But Elon Says Get Ready to Brace (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

ACTU Media Mentions By Week

ACTU Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACTU
News Sentiment

0.00

0.49

Average
Medical
News Sentiment

ACTU News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACTU Articles
This Week

0

1

ACTU Articles
Average Week

Get Actuate Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACTU and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ACTU) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners